Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 1,279 INKT shares, $14.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 1,279 | $14.0K |
| Jun 2, 2026 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 1,285 | $14.0K |
| Jan 6, 2026 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 5,395 | n/a |
| Dec 3, 2025 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 1,263 | $14.0K |
| Sep 11, 2025 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 3,225 | n/a |
| Sep 3, 2025 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 1,011 | $14.0K |
| Jun 4, 2025 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 1,953 | $14.0K |
| Mar 5, 2025 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 1,593 | $14.0K |
| Dec 3, 2024 | MiNK Therapeutics, Inc. (INKT) | Grant/Award | 20,476 | $14.9K |
| Oct 3, 2024 | AGENUS INC (AGEN) | Grant/Award | 3,423 | n/a |